winnerama80freespins|生物医药五月开门红,反弹开启了?

发布时间:2024-05-06编辑:editor阅读(13)

Stock speculation to see Jin Kirin analyst research report, authoritative, professional, timely, comprehensive, to help you tap the potential of the theme opportunity!

Today's opening (May 6, 2024), the biomedical industry has been rising for a long time! As of 10Winnerama80freespins: 10, the national card biomedical index rose by 3.Winnerama80freespins.88%, constituent stocks Zhaoyan New Drug limit, Jianfan Bio, Emick, Medisi, Yao Ming Kant, Kangtai Biology, Tiger Pharmaceuticals all rose more than 5%. Medicine before and after the festival has changed its declining trend and has risen one after another! The short-term stimulating factors include the increase of insulin collection price, the significant reduction of medicine Q1 position, the increment information of ASCO and so on.

Tianhong Foundation pointed out that in the medium term, the pharmaceutical industryWinnerama80freespinsThe bargaining chips are gradually cleared, and the trading atmosphere of Q2-Q3 is expected to improve. In addition, from a policy point of view, Beijing, Guangzhou and Zhuhai issued policies or draft proposals to support the development of pharmaceutical innovation almost at the same time in April. The three key points are the transformation of the financial guidance project, the innovation of clinical quantity and quality of drug equipment, and the exploration of broadening and innovative ways of drug equipment payment. In the future, pharmaceutical technology stocks with innovative drugs as the core are expected to become the focus of the market! The current valuation of the pharmaceutical industry is at a low level in the past 10 years, and its rigid demand attribute determines that the industry will have both growth and certainty in the future.

winnerama80freespins|生物医药五月开门红,反弹开启了?

Investors who want a low layout can follow the Tianhong National Certificate Biopharmaceutical ETF Link Fund (Class C share: 011041 Class A share: 011040); if they want to layout innovative drugs, they can follow the Tianhong Hang Seng Shanghai and Shenzhen Hong Kong Innovation Drug 50 Index (Class C share: 014565 Class A share: 014564). The individual stocks mentioned are for display only and are not recommended. There are risks in the market, so you need to be careful when investing.

标签

评论